NL7210812A - - Google Patents

Info

Publication number
NL7210812A
NL7210812A NL7210812A NL7210812A NL7210812A NL 7210812 A NL7210812 A NL 7210812A NL 7210812 A NL7210812 A NL 7210812A NL 7210812 A NL7210812 A NL 7210812A NL 7210812 A NL7210812 A NL 7210812A
Authority
NL
Netherlands
Application number
NL7210812A
Other versions
NL174550B (nl
NL174550C (nl
Inventor
V Zikan
M Semonsky
K Rezabek
M Seda
M Auskova
Original Assignee
Spofa Vereinigte Pharma Werke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CS570971A external-priority patent/CS156178B1/cs
Priority claimed from CS568971A external-priority patent/CS152153B1/cs
Application filed by Spofa Vereinigte Pharma Werke filed Critical Spofa Vereinigte Pharma Werke
Publication of NL7210812A publication Critical patent/NL7210812A/xx
Publication of NL174550B publication Critical patent/NL174550B/xx
Application granted granted Critical
Publication of NL174550C publication Critical patent/NL174550C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NLAANVRAGE7210812,A 1971-08-05 1972-08-07 Werkwijze ter bereiding van een lactatieremmende verbinding, werkwijze voor het bereiden van een geneesmiddel met lactatieremmende werking en gevormd geneesmiddel. NL174550C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CS570971A CS156178B1 (da) 1971-08-05 1971-08-05
CS568971A CS152153B1 (da) 1971-08-05 1971-08-05

Publications (3)

Publication Number Publication Date
NL7210812A true NL7210812A (da) 1973-02-07
NL174550B NL174550B (nl) 1984-02-01
NL174550C NL174550C (nl) 1984-07-02

Family

ID=25746228

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7210812,A NL174550C (nl) 1971-08-05 1972-08-07 Werkwijze ter bereiding van een lactatieremmende verbinding, werkwijze voor het bereiden van een geneesmiddel met lactatieremmende werking en gevormd geneesmiddel.

Country Status (12)

Country Link
US (1) US3953454A (da)
JP (1) JPS5247480B2 (da)
BE (1) BE787036A (da)
CA (1) CA976958A (da)
CH (2) CH573936A5 (da)
DE (1) DE2238540C3 (da)
DK (1) DK140500B (da)
FI (1) FI53127C (da)
FR (1) FR2150746B1 (da)
GB (1) GB1358358A (da)
NL (1) NL174550C (da)
SE (1) SE374111B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS522799A (en) * 1975-06-24 1977-01-10 Fuji Electric Co Ltd Control system for automatic sales machine
JPS522798A (en) * 1975-06-24 1977-01-10 Fuji Electric Co Ltd Control system for automatic sales machine
US4096266A (en) * 1976-04-06 1978-06-20 Hzi Research Center Lisuride in alcoholism
DE3063869D1 (en) * 1979-06-13 1983-07-28 Schering Ag (ergolin-yl)-n', n'-diethyl urea derivatives, their preparation and pharmaceutical compositions containing them
JPS5660173U (da) * 1979-10-09 1981-05-22
DE3001752A1 (de) * 1980-01-16 1981-07-30 Schering Ag Berlin Und Bergkamen, 1000 Berlin Verfahren zur herstellung von 8(alpha)-substituierten 6-methylergolinen
DE3101535A1 (de) * 1981-01-14 1982-08-12 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue (2-halogen-ergolinyl)-n'.n'-diethyl-harnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE3129714A1 (de) * 1981-07-23 1983-02-10 Schering Ag, 1000 Berlin Und 4619 Bergkamen Anti-psychotikum
DE3151912A1 (de) * 1981-12-23 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
DE3216869A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Synergistische kombination mit zytostatischer wirkung
DE3309493A1 (de) * 1983-03-14 1984-09-20 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ergolin-derivate, verfahren zu ihrer herstellung sowie verwendung als arzneimittel
DE3410218A1 (de) * 1984-03-16 1985-09-19 Schering AG, Berlin und Bergkamen, 1000 Berlin Tergurid als antihypertensivum
DE3413660A1 (de) * 1984-04-09 1985-10-17 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von 2-(trialkyl-silyl)-ergolinderivaten
DE3587860D1 (de) * 1984-04-09 1994-07-28 Schering Ag 2-substituierte Ergolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
DE3522894A1 (de) * 1985-06-24 1987-01-02 Schering Ag Verwendung von tergurid als geriatrikum
DE3533675A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-brom-ergolinderivate
DE3535930A1 (de) * 1985-10-04 1987-04-09 Schering Ag Neue 2-substituierte ergolinderivate
US5252335A (en) * 1989-07-12 1993-10-12 Cygnus Therapeutic Systems Transdermal administration of lisuride
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US9585885B2 (en) 2012-12-10 2017-03-07 Kissei Pharmaceutical Co., Ltd. Substituted pyrido[2,3-g]quinazolines as dopamine D2 receptor agonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3270020A (en) * 1966-08-30 Dihydro ergocornine
US3251846A (en) * 1966-05-17 G-dimethyosoergolenyl-b
CH344731A (de) * 1956-05-18 1960-02-29 Sandoz Ag Verfahren zur Herstellung von neuen, am Indolstickstoff alkylierten Derivaten der Lysergsäure-Reihe
GB1053507A (da) * 1964-04-14
US3681497A (en) * 1966-06-07 1972-08-01 Spofa Vereinigte Pharma Werke Therapeutic methods of employing hydrogen maleate salt of n-(d-6-methyl-8-isoergolenyl)-n{40 ,n{40 -diethyl-carbamide

Also Published As

Publication number Publication date
DE2238540A1 (de) 1973-02-22
DE2238540C3 (de) 1978-05-24
NL174550B (nl) 1984-02-01
FR2150746A1 (da) 1973-04-13
SE374111B (da) 1975-02-24
DE2238540B2 (de) 1977-09-29
JPS5247480B2 (da) 1977-12-02
US3953454A (en) 1976-04-27
CH573936A5 (da) 1976-03-31
DK140500B (da) 1979-09-17
FI53127B (da) 1977-10-31
JPS4826799A (da) 1973-04-09
CH573937A5 (da) 1976-03-31
DK140500C (da) 1980-02-11
CA976958A (en) 1975-10-28
NL174550C (nl) 1984-07-02
FR2150746B1 (da) 1976-07-02
BE787036A (fr) 1972-12-01
GB1358358A (en) 1974-07-03
FI53127C (da) 1978-02-10

Similar Documents

Publication Publication Date Title
DK140500C (da)
AU2691671A (da)
AU2952271A (da)
AU3005371A (da)
AU2742671A (da)
AU2894671A (da)
AU2684071A (da)
AU2941471A (da)
AU2837671A (da)
AU2854371A (da)
AU2706571A (da)
AU2724971A (da)
AU2726271A (da)
AU2740271A (da)
AU2836771A (da)
AU3038671A (da)
AU3025871A (da)
AU2885171A (da)
AU2963771A (da)
AU2875571A (da)
AU2880771A (da)
AU2940971A (da)
AU2938071A (da)
AU2755871A (da)
AU2930871A (da)

Legal Events

Date Code Title Description
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee